BUPROPION XR Sandoz cpr ret 150 mg bte 30 pce
7680686280021
CH-68628
N06AX12
01.06.0.
Reimbursement limitations:
WELLBUTRIN X
Traitement des épisodes dépressifs;
la thérapie doit être débutée par un psychiatre ou neurologue.
1 / 3
google
Details
- Product number
- 6862801
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- bupropioni hydrochloridum 150 mg, povidonum K 90, acidum hydrochloridum, natrii stearylis fumaras corresp. natrium 0.309 mg, ethylcellulosum, hydroxypropylcellulosum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, silica colloidalis anhydrica, macrogolum 1500, triethylis citras, Überzug: hypromellosum, macrogolum 400, macrogolum 8000, pro compresso obducto.
Articles (1)
Bupropion XR Sandoz 150 mg, Retardtabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.309 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 30.35
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/12/2024
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 68628
- Drug name
- Bupropion XR Sandoz, Retardtabletten
- Galenic form
- RETT
- ATC Code
- N06AX12
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 12/12/2023
- Authorization expiration date
- 11/12/2028
- IT number
- 01.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BUPROPION XR Sandoz cpr ret 150 mg bte 30 pce
- Description (DE)
- BUPROPION XR Sandoz Ret Tabl 150 mg Ds 30 Stk
- Market launch
- 12/12/2023
- Narcotic (BTM)
- No